# US 2020/0368513 A1 · Systems and Methods for Locating and Identifying an Implanted Medical Device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0368513 A1
- Document ID: US20200368513A1
- Status: Published application
- Kind: A1
- Application number: 16/961,213
- Filed: 2019-01-24
- Published: 2020-11-26
- Earliest claimed: 2018-01-26
- Assignees: Bard Peripheral Vascular, Inc.
- Applicants: Bard Peripheral Vascular, Inc.
- Inventors: Murtaza Y. Amin
- Web page: https://patentgrep.com/patent/US20200368513A1

## CPC

- A61B 90/98: using electromagnetic means, e.g. transponders
- A61M 39/0208: {Subcutaneous access sites (implantable infusion devices A61M5/14276; transcutaneous access sites A61M39/0247)}
- A61B 34/20: Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
- A61B 34/25: {User interfaces for surgical systems}
- A61M 5/14276: {specially adapted for implantation}
- G01S 13/75: using transponders powered from received waves, e.g. using passive transponders {, or using passive reflectors}
- A61B 2034/2051: {Electromagnetic tracking systems}
- A61M 2039/0238: {having means for locating the implanted device to insure proper injection, e.g. radio-emitter, protuberances, radio-opaque markers}
- A61M 2205/502: User interfaces, e.g. screens or keyboards
- A61M 2205/60: with identification means
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G01S: RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES

## Abstract

Systems and methods for detecting an implanted medical device, such as a vascular access port. The implanted medical device may include at least one passive RFID tag that has disposed thereon information about the implanted medical device. The at least one passive RFID tag is designed to be interrogated by a detector associated with an external device, such as an infusion set with an access needle. The interrogating signal induces a return signal from the at least one passive RFID tags. The strength of the return signal may be dependent on the distance and orientation of the tag relative to the detector. The system may be designed to interpret different signal strengths from different RFID tags to guide the needle to a correct insertion position, thereby accessing a port that cannot be readily detected visually or by palpation.

## Claims

### Claim at position 1

1-23. (canceled)

### Claim 24

A subcutaneous detection system, comprising:
a vascular access port system, comprising:
a body enclosing a fluid reservoir, an outlet of the body in communication with the fluid reservoir;
a needle-penetrable septum covering the fluid reservoir;
a catheter having a proximal end coupled to the outlet and a distal end including an opening; and
a RFID tag system, including at least a first RFID tag and a second RFID tag coupled to the body, the first RFID tag and the second RFID tag in a co-planar arrangement; and
an infusion set, comprising:
a detector providing an interrogation signal inducing the RFID tag system to provide a return signal; and
a needle extending through a central hole in the detector.

### Claim 25 (depends on 24)

The subcutaneous detection system according to claim 24, wherein the detector uses a strength of the return signal to determine a location of the RFID tag system relative to the detector.

### Claim 26 (depends on 24)

The subcutaneous detection system according to claim 24, wherein the detector uses a strength of the return signal to determine an orientation of the RFID tag system relative to the detector.

### Claim 27 (depends on 24)

The subcutaneous detection system according to claim 24, wherein the RFID tag system includes information encoded thereon pertaining to the vascular access port system.

### Claim 28 (depends on 27)

The subcutaneous detection system according to claim 27, wherein the information encoded on the RFID tag system is selected from the group consisting of make of the device, model of the device, device composition, device capabilities, date of manufacture, serial number, lot number, and combinations thereof.

### Claim 29 (depends on 24)

The subcutaneous detection system according to claim 24, further comprising a user interface device for interpreting and displaying information encoded in the return signal from the RFID tag system.

### Claim 30 (depends on 29)

The subcutaneous detection system according to claim 29, wherein the user interface device includes a display for depicting written, numerical, or iconic information about the vascular access port system.

### Claim 33 (depends on 29)

The subcutaneous detection system according to claim 29, wherein the user interface device includes a display for depicting written, numerical, or iconic information about the location and orientation of the vascular access port system.

### Claim 34 (depends on 29)

The subcutaneous detection system according to claim 29, wherein the user interface device includes one of a laptop, computer terminal, mobile device, palm top, smartphone, tablet, wearable device, smartwatch, heads up display (HUD), Virtual Reality (VR) device, and Augmented Reality (AR) device.

### Claim 35 (depends on 24)

The subcutaneous detection system according to claim 24, wherein the first RFID tag is positioned at a first port location of the vascular access port system, and wherein the second RFID tag is positioned at a second port location of the vascular access port system opposite of the first port location.

### Claim 36 (depends on 24)

The subcutaneous detection system according to claim 24, wherein the RFID tag system further comprises a third RFID tag co-planar with the first RFID tag and the second RFID tag, and wherein the first RFID tag is spaced equidistant from the second RFID tag and the third RFID tag.

### Claim 37 (depends on 36)

The subcutaneous detection system according to claim 36, wherein the first RFID tag, the second RFID tag, and the third RFID tag are spaced equidistant from a centerpoint of the needle-penetrable septum.

### Claim 38 (depends on 24)

The subcutaneous detection system according to claim 24, wherein the RFID tag system further comprises a third RFID tag and a fourth RFID tag, both co-planar with the first RFID tag and the second RFID tag, and wherein the first RFID tag, the second RFID tag, the third RFID tag, and the fourth RFID tag are spaced equidistant about the vascular access port system.

### Claim 39 (depends on 38)

The subcutaneous detection system according to claim 38, wherein the first RFID tag, the second RFID tag, the third RFID tag, and the fourth RFID tag are spaced equidistant from a centerpoint of the needle-penetrable septum.
